Regeneron Pharmaceuticals Inc (REGN) net margin is 31.9%
Regeneron Pharmaceuticals Inc (REGN) net margin is 31.9% as of 2025-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full REGN research page for quote, filings, and the rest of the model. This satellite exists so “Regeneron Pharmaceuticals Inc net margin” can rank with the actual number, then send you to /stock/regn.